Unimed Appoints Sune Svenningsen as CEO to Lead Global Expansion

Unimed appointed Sune Svenningsen as chief executive officer, succeeding Søren Andersen, to steer the medical supplier's global expansion, the company said on October 21, 2026. Svenningsen, a former International SOS executive, brings nearly 30 years of healthcare supply chain experience, according to EIN Presswire.

Svenningsen's Role and Prior Positions

Svenningsen will work with Unimed's leadership team, employees and board to advance the company's long-term growth strategy, the company said. He plans to visit its major operating centres during his first months as CEO.

He joined Unimed from International SOS, where he held several senior roles, including CEO of its supply division and chief operating officer of its medical services business. He previously held leadership positions at Novartis and Missionpharma, overseeing operations across Asia-Pacific, the Middle East, Europe and the Americas.

ZCG founder, president and CEO James J. Zenni said: "Sune brings deep experience in building international organisations, strengthening operational performance and leading complex global supply and distribution networks." Zenni added that Svenningsen's leadership will be valuable as Unimed continues expanding its maritime health, compliance and supply solutions around the world.

Svenningsen said Unimed has built a strong reputation for supporting the health and wellbeing of seafarers, and that he looked forward to getting to know its teams and customers and developing the services maritime operators rely on.

Unimed's Recent Acquisitions and Scale

Unimed is a portfolio company of ZCG Private Equity, the private equity fund management platform of Z Capital Group LLC, according to akta.pro company records. The same records show Unimed acquired Regenboog Shipping Pharmacy, a Rotterdam-based maritime pharmaceutical distributor with more than 1,000 SKUs and more than 300 customers, in February 2026, anchoring its Netherlands presence.

In December 2025, Unimed acquired Elssi Maritime Services, a Greek and Cypriot drug, alcohol and environmental testing provider, expanding its service portfolio and scaling vessels served to more than 18,000. ZCG Private Equity financial backing enabled the acquisition-led European expansion strategy across three bolt-on deals within approximately twelve months, the same records show.

Unimed's scale indicators list more than 14,000 vessels trusting it for business-critical products and digital services and more than 500,000 seafarers supported by its solutions. News reports cite more than 18,000 vessels served following the Elssi acquisition, while the company website states more than 14,000.

Svenningsen's First Months as CEO

Svenningsen plans to visit Unimed's major operating centres during his first months as CEO, the company said. Unimed was founded in 1976 and is headquartered in Staten Island, New York.